vs
Side-by-side financial comparison of CAMDEN NATIONAL CORP (CAC) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $64.3M, roughly 1.2× CAMDEN NATIONAL CORP). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 22.6%).
Camden National Bank is a commercial bank headquartered in Camden, Maine, operating as the principal subsidiary of Camden National Corporation, a publicly traded bank holding company. Founded in 1875, the bank became a direct, wholly owned subsidiary of the holding company following a corporate reorganization in 1984. Following the 2025 merger with Northway Financial, the combined institution has approximately $7.0 billion in assets.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
CAC vs PBYI — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $64.3M | $75.5M |
| Net Profit | $21.9M | — |
| Gross Margin | — | 69.3% |
| Operating Margin | — | 22.7% |
| Net Margin | 34.0% | — |
| Revenue YoY | — | 27.7% |
| Net Profit YoY | — | — |
| EPS (diluted) | $1.29 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $64.3M | — | ||
| Q4 25 | $68.1M | $75.5M | ||
| Q3 25 | $65.4M | $54.5M | ||
| Q2 25 | $62.3M | $52.4M | ||
| Q1 25 | $60.1M | $46.0M | ||
| Q4 24 | $47.6M | $59.1M | ||
| Q3 24 | $45.0M | $80.5M | ||
| Q2 24 | $42.8M | $47.1M |
| Q1 26 | $21.9M | — | ||
| Q4 25 | $22.6M | — | ||
| Q3 25 | $21.2M | $8.8M | ||
| Q2 25 | $14.1M | $5.9M | ||
| Q1 25 | $7.3M | $3.0M | ||
| Q4 24 | $14.7M | — | ||
| Q3 24 | $13.1M | $20.3M | ||
| Q2 24 | $12.0M | $-4.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% |
| Q1 26 | — | — | ||
| Q4 25 | 41.5% | 22.7% | ||
| Q3 25 | 40.5% | 17.6% | ||
| Q2 25 | 28.5% | 12.7% | ||
| Q1 25 | 10.3% | 8.7% | ||
| Q4 24 | 38.7% | 22.6% | ||
| Q3 24 | 35.2% | 27.4% | ||
| Q2 24 | 34.7% | -4.6% |
| Q1 26 | 34.0% | — | ||
| Q4 25 | 33.1% | — | ||
| Q3 25 | 32.4% | 16.2% | ||
| Q2 25 | 22.6% | 11.2% | ||
| Q1 25 | 12.2% | 6.5% | ||
| Q4 24 | 30.8% | — | ||
| Q3 24 | 29.1% | 25.2% | ||
| Q2 24 | 28.0% | -9.6% |
| Q1 26 | $1.29 | — | ||
| Q4 25 | $1.33 | $0.26 | ||
| Q3 25 | $1.25 | $0.17 | ||
| Q2 25 | $0.83 | $0.12 | ||
| Q1 25 | $0.43 | $0.06 | ||
| Q4 24 | $1.00 | $0.40 | ||
| Q3 24 | $0.90 | $0.41 | ||
| Q2 24 | $0.81 | $-0.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $97.5M |
| Total DebtLower is stronger | $514.4M | $22.7M |
| Stockholders' EquityBook value | $710.0M | $130.3M |
| Total Assets | $7.0B | $216.3M |
| Debt / EquityLower = less leverage | 0.72× | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | — | $96.8M |
| Q1 26 | $514.4M | — | ||
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M |
| Q1 26 | $710.0M | — | ||
| Q4 25 | $696.6M | $130.3M | ||
| Q3 25 | $676.4M | $115.3M | ||
| Q2 25 | $652.1M | $104.7M | ||
| Q1 25 | $640.1M | $97.1M | ||
| Q4 24 | $531.2M | $92.1M | ||
| Q3 24 | $529.9M | $71.1M | ||
| Q2 24 | $508.3M | $48.5M |
| Q1 26 | $7.0B | — | ||
| Q4 25 | $7.0B | $216.3M | ||
| Q3 25 | $7.0B | $202.9M | ||
| Q2 25 | $6.9B | $194.9M | ||
| Q1 25 | $7.0B | $196.2M | ||
| Q4 24 | $5.8B | $213.3M | ||
| Q3 24 | $5.7B | $220.7M | ||
| Q2 24 | $5.7B | $205.0M |
| Q1 26 | 0.72× | — | ||
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $14.4M |
| Free Cash FlowOCF − Capex | — | $14.4M |
| FCF MarginFCF / Revenue | — | 19.1% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $63.9M | $14.4M | ||
| Q3 25 | $36.1M | $9.7M | ||
| Q2 25 | $6.0M | $14.1M | ||
| Q1 25 | $1.0M | $3.6M | ||
| Q4 24 | $60.9M | $15.6M | ||
| Q3 24 | $-14.5M | $11.0M | ||
| Q2 24 | $14.5M | $1.0M |
| Q1 26 | — | — | ||
| Q4 25 | $58.2M | $14.4M | ||
| Q3 25 | $35.4M | $9.7M | ||
| Q2 25 | $4.5M | $14.1M | ||
| Q1 25 | $-727.0K | $3.6M | ||
| Q4 24 | $55.4M | $15.6M | ||
| Q3 24 | $-16.2M | $11.0M | ||
| Q2 24 | $13.2M | $1.0M |
| Q1 26 | — | — | ||
| Q4 25 | 85.5% | 19.1% | ||
| Q3 25 | 54.1% | 17.7% | ||
| Q2 25 | 7.3% | 26.8% | ||
| Q1 25 | -1.2% | 7.7% | ||
| Q4 24 | 116.4% | 26.4% | ||
| Q3 24 | -36.0% | 13.7% | ||
| Q2 24 | 30.8% | 2.1% |
| Q1 26 | — | — | ||
| Q4 25 | 8.4% | 0.0% | ||
| Q3 25 | 1.1% | 0.0% | ||
| Q2 25 | 2.4% | 0.0% | ||
| Q1 25 | 2.9% | 0.1% | ||
| Q4 24 | 11.7% | 0.0% | ||
| Q3 24 | 3.8% | 0.0% | ||
| Q2 24 | 3.0% | 0.0% |
| Q1 26 | — | — | ||
| Q4 25 | 2.83× | — | ||
| Q3 25 | 1.70× | 1.10× | ||
| Q2 25 | 0.43× | 2.41× | ||
| Q1 25 | 0.14× | 1.21× | ||
| Q4 24 | 4.15× | — | ||
| Q3 24 | -1.11× | 0.54× | ||
| Q2 24 | 1.21× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CAC
| Net Interest Income | $52.4M | 81% |
| Noninterest Income | $12.0M | 19% |
PBYI
Segment breakdown not available.
